InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 5 Nov 2015 7:31PM $0.125 $0.230 risen by 84%
- Quarterly Report & Company Update 30 Oct 2015 12:58PM $0.006 $0.230 risen by 3,733.33%
- Consolidation of Capital 28 Oct 2015 8:25AM $0.006 $0.230 risen by 3,733.33%
- Final Director's Interest Notice 28 Oct 2015 8:25AM $0.006 $0.230 risen by 3,733.33%
- Results of Annual General Meeting 27 Oct 2015 7:44PM $0.006 $0.230 risen by 3,733.33%
- PharmAust AGM Presentation 2015 27 Oct 2015 8:26AM $0.005 $0.230 risen by 4,500%
- Change of Director's Interest Notice 22 Oct 2015 8:28AM $0.005 $0.230 risen by 4,500%
- Clinical Trial Report Following Phase I Trial 21 Oct 2015 9:00AM $0.005 $0.230 risen by 4,500%
- Change of Registered Office & Principal Place of Business 19 Oct 2015 12:54PM $0.005 $0.230 risen by 4,500%
- Epichem's New Laboratory Completed 29 Sep 2015 9:38AM $0.005 $0.230 risen by 4,500%
- Consolidation/Split - PAA 22 Sep 2015 5:16PM $0.007 $0.230 risen by 3,185.71%
- PharmAust Annual Report 2015 22 Sep 2015 4:53PM $0.007 $0.230 risen by 3,185.71%
- Notice of Annual General Meeting/Proxy Form 22 Sep 2015 4:51PM $0.007 $0.230 risen by 3,185.71%
- Appendix 3B & 708 Notice 4 Sep 2015 11:35AM $0.007 $0.230 risen by 3,185.71%
- Appendix 4E & Full Year Statutory Accounts 28 Aug 2015 12:17PM $0.006 $0.230 risen by 3,733.33%
- Appendix 4G & Corporate Governance Statement 28 Aug 2015 12:08PM $0.006 $0.230 risen by 3,733.33%
- Professor Morris plans to retire from PharmAust board 24 Aug 2015 9:52AM $0.007 $0.230 risen by 3,185.71%
- Change of Director's Interest Notice 12 Aug 2015 10:05AM $0.007 $0.230 risen by 3,185.71%
- Clarification on Expiry of Listed Options 3 Aug 2015 12:56PM $0.008 $0.230 risen by 2,775%
- Letter to Optionholders 3 Aug 2015 10:56AM $0.008 $0.230 risen by 2,775%
- Appendix 4C - Quarterly Report & Company Update 28 Jul 2015 10:56AM $0.008 $0.230 risen by 2,775%
- Phase I Trial at RAH Meets Safety & Cancer Marker End Points 23 Jul 2015 9:26AM $0.008 $0.230 risen by 2,775%
- Trading Halt 22 Jul 2015 9:49AM $0.008 $0.230 risen by 2,775%
- First Two Canines Complete Combination Therapy With PPL-1 16 Jul 2015 8:29AM $0.009 $0.230 risen by 2,455.56%
- PharmAust Receives ATO Research & Development Rebate 24 Jun 2015 8:26AM $0.009 $0.230 risen by 2,455.56%

576 - 600 of 796 results

Page 24 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.